Communiqués LifeWatch AG Deutsche Boerse AG

Actions

GUA1

CH0012815459

Equipement et technologie médicale avancés

Temps Différé Deutsche Boerse AG Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		-4,08%	-

18/12/17	Lifewatch disparaîtra de SIX le 29 décembre, suite au rachat par BioTelemetry	AW
03/10/17	LifeWatch dépose une demande de décotation auprès de la Bourse suisse	AW

Communiqués

18/12/17	LifeWatch AG: Cancellation of all remaining publicly held registered shares of LifeWatch AG and delisting from the SIX Swiss Exchange, effective December 29, 2017	EQ
26/10/17	LifeWatch AG: LifeWatch delisting from SIX Swiss Exchange approved	EQ
03/10/17	LifeWatch AG: LifeWatch applies for delisting	EQ
28/08/17	LifeWatch AG: Exemption from Publicity Obligations under Listing Requirements	EQ
09/06/17	LifeWatch: Five-year Corporate Integrity Agreement Success - Fully Completed	PR
21/03/16	LifeWatch : Discloses Supplemental Information on Highmark Arbitration Case	PR
03/03/16	LifeWatch : TM) Appoints Andrew Moore as Chief Financial Officer	PR
09/02/16	LifeWatch : TM) Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service	PR
18/01/16	LifeWatch : Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch	PR
12/01/16	LifeWatch : AliveCor Partners with LifeWatch to Expand Into Remote Patient Monitoring	PR
10/11/15	LifeWatch : reg; acquires FlexLife Health Inc., an INR monitoring company co-founded by the Cleveland Clinic	PU
08/10/15	LifeWatch : Change in the Board of Directors at LifeWatch AG	PU
14/09/15	LifeWatch : receives FDA clearance to run its ACT software on the Android™ operating system	PU
20/08/15	LifeWatch : Reports Above-Market Revenue Growth of 9.1% and Substantial Improvement in Profitability During First Half 2015	BU
29/07/15	LifeWatch : expects a positive net income for the first half of 2015	PU
13/07/15	LifeWatch : signs agreement to bring its cardiac monitoring business to the Turkish market	PU
02/03/15	LifeWatch : Suit Brought Against LifeWatch Services, Inc. by Acacia Subsidiary Dismissed	BU
22/12/14	LifeWatch : receives FDA 510(k) clearance for its Vital Signs Patch (VSP)	PU
08/12/14	LifeWatch : Stefan Vogt named Chief Commercial Officer	PU
07/11/14	LifeWatch : Agreement signed to utilize Vital Connect Inc.'s HealthPatch(R) MD in its cardiac monitoring business	BU
17/10/14	LifeWatch : Services, Inc. and LifeWatch AG announces the reinstatement of Cigna Corporation’s coverage of mobile cardiac monitoring services	PU
16/10/14	LifeWatch : Services, Inc. and LifeWatch AG announces the reinstatement of Cigna Corporation's coverage of mobile cardiac monitoring services	BU
20/08/14	LifeWatch : achieves volume growth of 13.1% in the first half of 2014	PU
12/08/14	LifeWatch : Roger Richardson leaves LifeWatch	PU
27/05/14	LifeWatch : reports solid revenue growth in first quarter 2014 and is poised for further organic growth	PU